
The Wall Street Journal @WSJ
CBD oils and other cannabis-derived products require closer regulation because of safety risks, the Food and Drug Administration said, as it seeks new powers to regulate cannabidiol products from Congress https://t.co/qRLhAbJFAi — PolitiTweet.org